secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001140361-23-028397
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis appoints Michael McCormick to board as Lead Independent Director; Warren Watson resigns
--------------------------------------------------------------------------------

- McCormick appointed Class I director effective June 1, 2023, as Lead Independent Director, Audit Committee member, and Nominating Committee Chair.
- McCormick receives $45K annual retainer plus $10K Lead Director fee, $7.5K Audit Committee, $10K Nominating Chair.
- Warren Watson resigned June 2, 2023, from board and all committees; no disagreement with company.
- McCormick has 25+ years med device experience, formerly CEO of Osprey Medical and Anulex Technologies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123028397/0001140361-23-028397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036123028397/brhc20054036_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-028397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer